Product Information
Technical Data
| Specification | Description |
|---|---|
| Stent Design | Direct-Stent - Patented Hybrid Cell Design, Stent Ends Flarable |
| Stent Material | L605 Cobalt Chromium Alloy |
| Stent Covering Polymer | ePTFE Microporous Polymer, IND 90-120 μm |
| Wall Thickness | 0.086 ±0.010 mm |
| Balloon System | Rx Rapid Exchange Balloon Catheter |
| Balloon Material | Semi-Compliant - Nylon / Pebax Blend |
| Optimal Deployment Pressure | 10 ATM |
| **Nominal Pressure | 10 ATM |
| Rated Burst Pressure | 16 ATM (2.25-4.0 mm); 14 ATM (4.5-6.0 mm) |
| Shaft Size (Proximal/Distal) | 2F / 2.7F |
| *Minimum Guiding Catheter | 5F (2.25-3.0 mm); 6F (3.5-6.0 mm) |
| Crimped Profile | 0.95-1.4 mm |
| Tip Entry Profile | 0.016-0.017 inch |
| Recommended Guidewire | 0.014 inch |
| Delivery Catheter Length | 142 ±10 cm usable length |
| Stent Length | 10-30 mm standard; 6.0 mm custom lengths per ordering table |
| Stent Ends Flaring | 2.25, 2.5, 2.75 → 3.5 mm; 3.0-4.5 → 5 mm; 5.0, 6.0 → 7 mm |
| Radial Force | 3-2.5 mm | 1.3 N Force |
* See individual manufacturer for Guide Catheter Fr equivalent.
** Assure full deployment of stent. Deployment pressures should be based on lesion characteristics.
Technical data should be read with the applicable approved Instructions for Use. Specifications and availability may vary by market.
Configurations
Ordering Information
| Stent Diameter (mm) | Stent Length (mm) | Ordering Number |
|---|---|---|
| 2.25 | 10, 13, 16, 19, 23, 26 | 76225XX |
| 2.5 | 10, 13, 16, 19, 23, 26, 30 | 7625XX |
| 2.75 | 10, 13, 16, 19, 23, 26, 30 | 76275XX |
| 3.0 | 10, 13, 16, 19, 23, 26, 30 | 7630XX |
| 3.5 | 10, 13, 16, 19, 23, 26, 30 | 7635XX |
| 4.0 | 10, 13, 16, 19, 23, 26, 30 | 7640XX |
| 4.5 | 15, 19, 23, 26, 30 | 7645XX |
| 5.0 | 17, 20, 27 | 7650XX |
| 6.0* | 17, 20, 27, 30, 34, 37 | 7660XX |
* Custom Orders (6.0 mm diameter).
XX denotes the selected length, including a leading zero where shown. Example: 2.25 × 10 mm. Ordering number: 7622510.
Confirm configurations and ordering information against the current approved product documentation.





